John Lazarchick to Recombinant Proteins
This is a "connection" page, showing publications John Lazarchick has written about Recombinant Proteins.
Connection Strength
0.176
-
Use of bivalirudin to prevent thrombosis following orthotopic liver transplantation in a patient with Budd-Chiari syndrome and a history of heparin-induced thrombocytopenia. Ann Clin Lab Sci. 2008; 38(3):277-82.
Score: 0.068
-
Use of recombinant factor VIIa in infants with severe coagulopathy. J Perinatol. 2004 May; 24(5):310-1.
Score: 0.053
-
Administration of recombinant activated factor VII in the intensive care unit after complex cardiovascular surgery: clinical and economic outcomes. J Thorac Cardiovasc Surg. 2011 Jun; 141(6):1469-77.e2.
Score: 0.021
-
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery. Ann Thorac Surg. 2008 May; 85(5):1669-76; discussion 1676-7.
Score: 0.017
-
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thromb Haemost. 2008 Mar; 99(3):616-22.
Score: 0.017